Prevalence of factor V Leiden mutation in various populations

被引:0
|
作者
Herrmann, FH
Koesling, M
Schroder, W
Altman, R
Bonilla, RJ
Lopaciuk, S
PerezRequejo, JL
Singh, JR
机构
[1] HOSP NATL NINOS,SAN JOSE,COSTA RICA
[2] INST HEMATOL & BLOOD TRANSFUS,WARSAW,POLAND
[3] BANCO SANGRE DE CARABOBO,VALENCIA,VENEZUELA
[4] UNIV AMRITSAR,CTR GENET DISORDERS,AMRITSAR,PUNJAB,INDIA
关键词
frequency of APC resistance; factor V Leiden in Middle and South America; India;
D O I
10.1002/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Resistance to activated protein C (APC) is the most common inherited risk factor for venous thrombosis. Most cases of APC resistance are caused by the point mutation nt 1691 G-A in factor V gene, referred to as factor V Leiden mutation. As initially shown in a Dutch population, this mutation has a carrier rate of 2.9%, the most frequent genetic disposition for thrombophilia and deep venous thrombosis. By large-scale epidemiological studies we have determined the prevalence of factor V Leiden mutation in populations from Poland (200), Argentina (215), Venezuela (126), Costa Pica (196), and India (150). The prevalences have been estimated for Poland (Warsaw) 5.0%, Argentina (Buenos Aires) 5.1%, Venezuela (Valencia) 1.6%, Costa Pica (San Jose) 2.0%, and India (Punjab) 1.3%. Based on worldwide distribution, it can be hypothesized that the factor V Leiden mutation has originated and accumulated in central European Caucasians and spread over the world by migration. (C) 1997 Wiiey-Liss, Inc.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 50 条
  • [21] The distribution of Factor V Leiden mutation
    Aydan Eroğlu
    Journal of Thrombosis and Thrombolysis, 2013, 36 : 341 - 342
  • [22] Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation
    Saemundsson, Ymir
    Sveinsdottir, Signy Vala
    Svantesson, Henrik
    Svensson, Peter J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (03) : 324 - 331
  • [23] Homozygous factor V Leiden and compound heterozygosity for factor V Leiden and prothrombin mutation
    Saemundsson, Y.
    Sveinsdottir, S., V
    Svantesson, H.
    Svensson, P. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 151 - 151
  • [24] Prevalence of factor V Leiden and prothrombin G20210A gene mutation
    Al-Aama, JY
    SAUDI MEDICAL JOURNAL, 2005, 26 (11) : 1844 - 1844
  • [25] Prevalence of factor V Leiden and prothrombin G20210A gene mutation
    Irdem, A
    Devecioglu, C
    Batun, S
    Soker, M
    Sucakli, IA
    SAUDI MEDICAL JOURNAL, 2005, 26 (04) : 580 - 583
  • [26] The prevalence of factor V Leiden (1691 G->A) mutation in Turkey.
    Gurgey, A
    Mesci, L
    TURKISH JOURNAL OF PEDIATRICS, 1997, 39 (03) : 313 - 315
  • [27] The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency
    Maessen-Visch, MB
    Hamulyak, K
    Tazelaar, DJ
    Crombag, NHCMN
    Neumann, HAM
    ARCHIVES OF DERMATOLOGY, 1999, 135 (01) : 41 - 44
  • [28] Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease.
    Hagstrom, JN
    Walter, J
    BluebondLangner, R
    Manno, CS
    High, KA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 917 - 917
  • [29] The distribution of factor V Leiden mutation in three different ethnic populations in the former USSR
    Baranovskaya, S
    Kudinov, S
    Schwartz, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS905 - PS905
  • [30] World distribution of factor V Leiden mutation
    deMaat, MPM
    Kluft, C
    Jespersen, J
    Gram, J
    LANCET, 1996, 347 (8993): : 58 - 58